Immediate early response gene X-1, a potential prognostic biomarker in cancers

Expert Opinion on Therapeutic Targets

Volumn 17, Issue 5, 2013, Pages 593-606

  Wu, Mei X ^a,b   Ustyugova, Irina V ^a,e   Han, Liping ^c   Akilov, Oleg E ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e Sanofi Pasteur Biologics Co   (United States)

Author keywords

Apoptosis; Biomarkers; Cancer prognosis; IF1; Immediate early response gene X 1

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; INTERLEUKIN 12; INTERLEUKIN 6; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BREAST CANCER; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLORECTAL CANCER; CUTANEOUS T CELL LYMPHOMA; EARLY RESPONSE GENE; EARLY RESPONSE GENE X 1; GENE ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOPRECIPITATION; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PANCREAS CANCER; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; GENES, IMMEDIATE-EARLY; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876245655     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2013.768234     Document Type: Review

References (79)

1. Wu MX. Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis 2003;8:11-18
2. Arlt A, Schafer H. Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis. Eur J Cell Biol 2011;90:545-52
3. Arlt A, Rosenstiel P, Kruse ML, et al. IEX-1 directly interferes with RelA/ p65 dependent transactivation and regulation of apoptosis. Biochim Biophys Acta 2008;1783:941-52 . IEX-1 functions as a corepressor
4. Hamidi T, Algul H, Cano CE, et al. Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. J Clin Invest 2012;122:2092-103
5. Han L, Geng L, Liu X, et al. Clinical significance of IEX-1 expression in ovarian carcinoma. Ultrastruct Pathol 2011;35:260-6
6. Sasada T, Azuma K, Hirai T, et al. Prognostic significance of the immediate early response gene X-1 (IEX-1) expression in pancreatic cancer. Ann Surg Oncol 2008;15:609-17
7. Gonzalez S, Perez-Perez MM, Hernando E, et al. p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibition. Cancer Res 2005;65:2186-92
8. Wu MX, Ao Z, Prasad KV, et al. IEX- 1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 1998;281:998-1001
9. Yoon S, Ha HJ, Kim YH, et al. IEX-1-induced cell death requires BIM and is modulated by MCL-1. Biochem Biophys Res Commun 2009;382:400-4
10. Rechsteiner M, Rogers SW. PEST sequences and regulation by proteolysis. Trends Biochem Sci 1996;21:267-71
11. Shen L, Guo J, Santos-Berrios C, et al. Distinct domains for anti- and pro-apoptotic activities of IEX-1. J Biol Chem 2006;281:15304-11
12. Shen L, Zhi L, Hu W, et al. IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation. Cell Death Differ 2009;16:603-12
13. Kruse ML, Arlt A, Sieke A, et al. Immediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells. J Biol Chem 2005;280:24849-56
14. Feldmann KA, Pittelkow MR, Roche PC, et al. Expression of an immediate early gene, IEX-1, in human tissues. Histochem Cell Biol 2001;115:489-97.
15. Gao YQ, Yang W, Karplus M. A structure-based model for the synthesis and hydrolysis of ATP by F1-ATPase. Cell 2005;123:195-205
16. Jezek P, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 2005;37:2478-503
17. Schwerzmann K, Pedersen PL. Regulation of the mitochondrial ATP synthase/ATPase complex. Arch Biochem Biophys 1986;250:1-18
18. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-64
19. Campanella M, Casswell E, Chong S, et al. Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab 2008;8:13-25
20. Formentini L, Sanchez-Arago M, Sanchez-Cenizo L, et al. The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response. Mol Cell 2012;45:731-42
21. Sanchez-Cenizo L, Formentini L, Aldea M, et al. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. J Biol Chem 2010;285:25308-13
22. Akilov OE, Ustyugova IV, Zhi L, et al. Enhanced susceptibility to Leishmania infection in resistant mice in the absence of immediate early response gene X-1. J Immunol 2009;183:7994-8003
23. Zhi L, Ustyugova IV, Chen X, et al. Enhanced Th17 differentiation and aggravated arthritis in IEX-1-deficient mice by mitochondrial reactive oxygen species-mediated signaling. J Immunol 2012;189:1639-47
24. Ustyugova IV, Zhi L, Wu MX. Reciprocal regulation of the survival and apoptosis of Th17 and Th1 cells in the colon. Inflamm Bowel Dis 2012;18:333-43
25. Zhang Y, Schlossman SF, Edwards RA, et al. Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci USA 2002;99:878-83
26. Barbato JC. Have no fear, MitoQ10 is here. Hypertension 2009;54:222-3
27. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-84
28. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-64
29. Lumeng CN, DelProposto JB, Westcott DJ, et al. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008;57:3239-46
30. Lo CC, Scadden D. Isolation and transplantation of hematopoietic stem cells (HSCs). J Vis Exp 2007;157
31. Hamelin V, Letourneux C, Romeo PH, et al. Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation. Blood 2006;107:3106-13
32. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002;21:3359-67
33. Letourneux C, Rocher G, Porteu F. B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J 2006;25:727-38
34. Rocher G, Letourneux C, Lenormand P, et al. Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity. J Biol Chem 2007;282:5468-77
35. Harada H, Harada Y, Niimi H, et al. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Blood 2004;103:2316-24
36. Imai Y, Kurokawa M, Izutsu K, et al. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. Blood 2000;96:3154-60
37. Pawlikowska P, Leray I, de Laval B, et al. ATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage response. Cell Death Differ 2010;17:1739-50
38. Arlt A, Minkenberg J, Kruse ML, et al. Immediate early gene-X1 interferes with 26 S proteasome activity by attenuating expression of the 19 S proteasomal components S5a/Rpn10 and S1/Rpn2. Biochem J 2007;402:367-75
39. Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 2005;6:599-609
40. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108
41. Lee YH, Kim JH, Zhou H, et al. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. J Mol Med (Berl) 2012;90:427-34
42. Kaur S, Baine MJ, Jain M, et al. Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med 2012;6:597-612
43. Schafer H, Lettau P, Trauzold A, et al. Human PACAP response gene 1 (p22/ PRG1): proliferation-associated expression in pancreatic carcinoma cells. Pancreas 1999;18:378-84
44. Prall WC, Czibere A, Grall F, et al. Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome. Int J Hematol 2009;89:173-87
45. Haase D, Germing U, Schanz J, et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007;110:4385-95
46. Hofmann WK, de Vos S, Komor M, et al. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 2002;100:3553-60
47. Steensma DP, Neiger JD, Porcher JC, et al. Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes. Cancer Res 2009;69:7518-23
48. Davids MS, Steensma DP. The molecular pathogenesis of myelodysplastic syndromes. Cancer Biol Ther 2010;10:309-19
49. Ria R, Todoerti K, Berardi S, et al. Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma. Clin Cancer Res 2009;15:5369-78
50. Bradford PT, Devesa SS, Anderson WF, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 2009;113:5064-73
51. Wu J, Nihal M, Siddiqui J, et al. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation. J Invest Dermatol 2009;129:1165-73
52. Zhang Y, Finegold MJ, Porteu F, et al. Development of T-cell lymphomas in Emu-IEX-1 mice. Oncogene 2003;22:6845-51
53. Akilov OE, Wu MX, Ustyugova IV, et al. Resistance of Sezary cells to TNF-alpha-induced apoptosis is mediated in part by a loss of TNFR1 and a high level of the IER3 expression. Exp Dermatol 2012;21:287-92
54. Wollina U. Cutaneous T cell lymphoma: update on treatment. Int J Dermatol 2012;51:1019-36
55. Mathiasen IS, Hansen CM, Foghsgaard L, et al. Sensitization to TNF-induced apoptosis by 1,25-dihydroxy vitamin D(3) involves up-regulation of the TNF receptor 1 and cathepsin B. Int J Cancer 2001;93:224-31
56. Gomez-Santos C, Francisco R, Gimenez-Xavier P, et al. Dopamine induces TNFalpha and TNF-R1 expression in SH-SY5Y human neuroblastoma cells. Neuroreport 2007;18:1725-8
57. Uwagawa T, Li Z, Chang Z, et al. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death. Cancer 2007;109:2142-53
58. Kumar R, Pittelkow MR, Salisbury JL, et al. A novel vitamin D-regulated immediate-early gene, IEX-1, alters cellular growth and apoptosis. Recent Results Cancer Res 2003;164:123-34
59. Kalivendi SV, Konorev EA, Cunningham S, et al. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J 2005;389:527-39
60. Hideshima T, Richardson P, Chauhan D, et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 2001;61:3071-6
61. Mitsiades N, Mitsiades CS, Richardson PG, et al. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications. Blood 2003;101:2377-80
62. Zinzani PL, Musuraca G, Tani M, et al. Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. J Clin Oncol 2007;25:4293-7
63. Huang YH, Wu JY, Zhang Y, et al. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes. Oncogene 2002;21:6819-28
64. Schafer H, Diebel J, Arlt A, et al. The promoter of human p22/PACAP response gene 1 (PRG1) contains functional binding sites for the p53 tumor suppressor and for NFkappaB. FEBS Lett 1998;436:139-43
65. Berges C, Haberstock H, Fuchs D, et al. Proteasome inhibition activates the mitochondrial pathway of apoptosis in human CD4+ T cells. J Cell Biochem 2009;108:935-46
66. Yang C, Trent S, Ionescu-Tiba V, et al. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression. Cancer Res 2006;66:11649-58
67. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012;21:297-308
68. Chariot A, Castronovo V. Detection of HOXA1 expression in human breast cancer. Biochem Biophys Res Commun 1996;222:292-7
69. Mohankumar KM, Xu XQ, Zhu T, et al. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene 2007;26:3998-4008
70. Burchiel SW, Thompson TA, Lauer FT, et al. Activation of dioxin response element (DRE)-associated genes by benzo (a)pyrene 3,6-quinone and benzo(a) pyrene 1,6-quinone in MCF-10A human mammary epithelial cells. Toxicol Appl Pharmacol 2007;221:203-14
71. Hockley SL, Arlt VM, Brewer D, et al. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2. BMC Genomics 2006;7:260
72. Hu Y, Sun H, Drake J, et al. From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies. Cancer Res 2004;64:7748-55
73. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31, 1
74. Nambiar PR, Nakanishi M, Gupta R, et al. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer. Cancer Res 2004;64:6394-401
75. Ustyugova IV, Zhi L, Abramowitz J, et al. IEX-1 deficiency protects against colonic cancer. Mol Cancer Res 2012;10:760-7
76. Segditsas S, Sieber O, Deheragoda M, et al. Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice. Hum Mol Genet 2008;17:3864-75
77. Hiss D. Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. J Oncol 2012;2012:737981
78. Arlt A, Grobe O, Sieke A, et al. Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells. Oncogene 2001;20:69-76
79. Yamashita K, Nakashima S, You F, et al. Overexpression of immediate early gene X-1 (IEX-1) enhances gamma-radiation-induced apoptosis of human glioma cell line, U87-MG. Neuropathology 2009;29:20-4